Covered recipient · General Payments record
CRYSTAL MOORE TRAVIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023
$292.99
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.99 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $150.12 | 10 |
| ABBVIE INC. | $72.87 | 4 |
| Corcept Therapeutics | $24.21 | 1 |
| Lilly USA, LLC | $18.06 | 1 |
| Acerta Pharma LLC | $15.01 | 1 |
| Exact Sciences Corporation | $12.72 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $292.99 | 18 |
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.50 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010062465 | CMS |
| ABBVIE INC. | $18.95 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010062469 | CMS |
| ABBVIE INC. | $15.19 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010062473 | CMS |
| ABBVIE INC. | $19.23 | 07/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010062477 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.01 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014295917 | CMS |
| Corcept Therapeutics | $24.21 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050816851 | CMS |
| Exact Sciences Corporation | $12.72 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026863367 | CMS |
| Lilly USA, LLC | $18.06 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032868607 | CMS |
| Novo Nordisk Inc | $16.97 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605559 | CMS |
| Novo Nordisk Inc | $2.19 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605535 | CMS |
| Novo Nordisk Inc | $18.80 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605607 | CMS |
| Novo Nordisk Inc | $17.24 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605571 | CMS |
| Novo Nordisk Inc | $17.76 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605583 | CMS |
| Novo Nordisk Inc | $17.92 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605595 | CMS |
| Novo Nordisk Inc | $16.35 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605547 | CMS |
| Novo Nordisk Inc | $20.70 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605631 | CMS |
| Novo Nordisk Inc | $20.02 | 07/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605619 | CMS |
| Novo Nordisk Inc | $2.17 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002605523 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.